2-甲基-1-(2-哌啶基)-1-丙酮 | 59576-30-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-甲基-1-(2-哌啶基)-1-丙酮
• 中文别名: 异丙基-2-吡啶酮
• 英文名称: 2-methyl-1-(pyridin-2-yl)propan-1-one
• 英文别名: isopropyl-2-pyridyl ketone；Isopropyl 2-pyridyl ketone；2-methyl-1-pyridin-2-ylpropan-1-one
• CAS: 59576-30-6
• 化学式: C₉H₁₁NO
• 分子量: 149.192
• InChiKey: OPPJOYDMQXHCFS-UHFFFAOYSA-N

物化性质

• 熔点：
  179-180 °C
• 沸点：
  112 °C(Press: 30 Torr)
• 密度：
  1.010±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Isopropyl 2-pyridyl ketone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Isopropyl 2-pyridyl ketone
CAS number: 59576-30-6

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C9H11NO
Molecular weight: 149.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-甲基-1-(2-哌啶基)-1-丙酮 在 羟胺 、 溴 作用下， 以 甲醇 、 乙醚 、 乙醇 、 水 、 溶剂黄146 为溶剂， 反应 77.5h， 生成 2-(4-Hexadecyloxy-phenyl)-5,5-dimethyl-3-oxy-4-pyridin-2-yl-2,5-dihydro-imidazol-1-ol
  参考文献：
  名称：

  N-[1-羟基亚氨基-2-甲基-1-(2-吡啶基)丙-2-基]羟胺及其杂环衍生物的合成与性质

  摘要：

  合成了 N-[1-Hydroxyimino-2-methyl-1-(2-pyridyl)prop-2-yl] 羟胺，这是 α-羟氨基肟系列的新代表。在此基础上，获得了3-咪唑啉3-氧化物和2-咪唑啉3-氧化物衍生物，并研究了它们的一些化学性质。

  DOI：

  10.1007/bf02495361
• 作为产物：
  描述：

  2-吡啶乙腈 在 sodium hydroxide 、 苄基三乙基氯化铵 作用下， 以 甲苯 为溶剂， 反应 24.0h， 生成 2-甲基-1-(2-哌啶基)-1-丙酮
  参考文献：
  名称：

  Hermann, Christine K. F.; Sachdeva, Yesh P.; Wolfe, James F., Journal of Heterocyclic Chemistry, 1987, vol. 24, p. 1061 - 1065

  摘要：

  DOI：

文献信息

• HETEROBICYCLIC COMPOUNDS
  申请人：Amgen Inc.

  公开号：US20130225552A1

  公开（公告）日：2013-08-29

  Heterobicyclic compounds of Formula (I): or a pharmaceutically-acceptable salt, tautomer, or stereoisomer thereof, as defined in the specification, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, Huntington's Disease, and the like.

  Formula (I)的杂环化合物： 或其药用可接受的盐、互变异构体或立体异构体，如规范中所定义，并含有它们的组合物，以及制备这种化合物的方法。本文还提供了通过抑制PDE10来治疗由此可治疗的疾病或疾病的方法，如肥胖症、非胰岛素依赖型糖尿病、精神分裂症、躁郁症、强迫症、亨廷顿病等。
• [EN] MACROCYCLIC COMPOUNDS FOR MODULATING IL-17<br/>[FR] COMPOSÉS MACROCYCLIQUES POUR UNE MODULATION D'IL-17
  申请人：ENSEMBLE THERAPEUTICS CORP

  公开号：WO2013116682A1

  公开（公告）日：2013-08-08

  The invention relates generally to macrocyclic compounds of formula I and their therapeutic use. More particularly, the invention relates to macrocyclic compounds that modulate the activity of IL-17 and/or are useful in the treatment of medical conditions, such as inflammatory diseases and other IL-17-associated disorders.

  这项发明通常涉及公式I的大环化合物及其治疗用途。更具体地，该发明涉及调节IL-17活性的大环化合物，或者用于治疗炎症性疾病和其他与IL-17相关的疾病的大环化合物。
• Copper-Catalyzed Synthesis of Esters from Ketones. Alkyl Group as a Leaving Group
  作者：Yuji Nakatani、Yuichiro Koizumi、Ryu Yamasaki、Shinichi Saito

  DOI：10.1021/ol800576w

  日期：2008.5.1

  The conversion of ketones to esters has been achieved through the use of Cu catalyst and tetrabutylammonium nitrite. This reaction involves the activation of the less activated C-C bond, and the alkyl group is removed as a leaving group. Various isopropyl ketones are found to be good substrates for this reaction.

  通过使用铜催化剂和亚硝酸四丁铵，已将酮转化为酯。该反应涉及活化程度较低的CC键的活化，并且烷基作为离去基团被除去。发现各种异丙基酮是该反应的良好底物。
• α-羟基酮化合物的廉价高效合成方法
  申请人：北京大学

  公开号：CN104710256B

  公开（公告）日：2017-03-22

  本发明公开了一种α‑羟基酮化合物的廉价高效合成方法。该合成方法包括：在常压条件下，以碘单质、N‑溴代丁二酰亚胺、溴化铜、溴单质、溴化氢、N‑碘代丁二酰亚胺或碘化氢作为催化剂，以亚砜为氧化剂，以水或亚砜为羟基源，以亚砜，乙酸乙酯、N,N‑二甲基甲酰胺、乙腈、甲苯、1,4‑二氧六环、1,2‑二氯乙烷、四氢呋喃或H2O为溶剂，与羰基化合物混合于10‑120℃温度下进行氧化羟基化反应即可将羰基化合物高选择性的转化为α‑羟基酮化合物。本发明方法与传统合成方法相比具有操作简单，收率高，条件简单，易于纯化，废弃物排放量少，反应设备简单，易于工业化生产等诸多优点。本发明的方法具有广泛地适用性，能够用于多种α‑羟基酮化合物的合成。
• Iron-Catalyzed Methylation Using the Borrowing Hydrogen Approach
  作者：Kurt Polidano、Benjamin D. W. Allen、Jonathan M. J. Williams、Louis C. Morrill

  DOI：10.1021/acscatal.8b02158

  日期：2018.7.6

  developed using methanol as a C1 building block. This borrowing hydrogen approach employs a Knölker-type (cyclopentadienone)iron carbonyl complex as catalyst (2 mol %) and exhibits a broad reaction scope. A variety of ketones, indoles, oxindoles, amines, and sulfonamides undergo mono- or dimethylation in excellent isolated yields (>60 examples, 79% average yield).

  使用甲醇作为C1结构单元，已经开发了一种一般的铁催化的甲基化方法。这种借入氢的方法采用Knölker型（环戊二烯酮）羰基铁络合物作为催化剂（2mol％），并显示出广泛的反应范围。各种酮类，吲哚类，吲哚类，胺类和磺酰胺类均以优异的分离收率（> 60例，平均收率79％）进行单-或二甲基化反应。